A

Boston biotechnology startup that uses plastic chips to simulate human organs to test medicines outside of the body said Tuesday that two more pharmaceutical giants and a major California teaching hospital plan to use its technology to develop drugs.

Emulate, which makes so-called organ-on-a-chip systems to test whether drugs are safe and effective, announced partnerships with Japan-based Takeda Pharmaceutical (TKPYY), Swiss-based Roche (RHHBY), and Cedars-Sinai Medical Center, of Los Angeles.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy